Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Ledum Palustre Globule 1dh - 30ch 1 Dh Tablet is a Health Canada–registered human drug (DIN 00682721) held by Boiron Laboratoires, containing Ledum Palustre. Health Canada lists its status as Cancelled Post Market (status date 16 Feb 1998). Nexara Health has matched 17 registrations of Ledum Palustre across 3 other regulated markets, 1 of them in the same strength and dosage form.

Health Canada registration

DIN00682721
Brand nameLedum Palustre Globule 1dh - 30ch
Active ingredientLedum Palustre
Strength1 Dh
Dosage formTablet
RouteOral
CompanyBoiron Laboratoires
StatusCancelled Post Market — 16 Feb 1998
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Ledum Palustre registered in other markets

17 registrations of the same molecule in 3 national registries outside Canada (first 13 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
NetherlandsLedum palustreVSM Geneesmiddelen B.V.TabletUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMGlobuliUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreVSM Geneesmiddelen B.V.Druppels voor oraal gebruik, oplossingUitsluitend apotheek of drogistEU national register
NetherlandsLedum palustreBOIRON (Messimy)4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LMUitsluitend apotheek of drogistEU national register
United Arab EmiratesLedum Palustre - BoironBOIRON, France, MessimyMT to 200 CHPillulesActiveEDE
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesLedum PalustreHahnemann Laboratories, INC.PelletlistedFDA NDC

See every manufacturer of Ledum Palustre worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Ledum Palustre Globule 1dh - 30ch (DIN 00682721) marketed in Canada?

No. Health Canada lists DIN 00682721 as Cancelled Post Market as of 16 Feb 1998.

Who holds the Canadian licence for this product?

Boiron Laboratoires is the company of record in the Health Canada Drug Product Database.

Is Ledum Palustre registered outside Canada?

Yes — Nexara Health has matched 17 registrations in 3 other markets, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00682721, status date 1998-02-16; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00682721, status date 1998-02-16; national medicine registries: EDE, EU national register, FDA NDC.

Health Canada Drug Product Database (DPD), DIN 00682721, status date 1998-02-16; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.